Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00116844-M01 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#H00116844-M01, RRID:AB_669593
- Product name
- Mouse Monoclonal LRG1 Antibody
- Antibody type
- Monoclonal
- Description
- IgG purified. leucine-rich alpha-2-glycoprotein 1
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Submitted references Type 1 Diabetes: Urinary Proteomics and Protein Network Analysis Support Perturbation of Lysosomal Function.
Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis.
Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms.
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin.
Singh H, Yu Y, Suh MJ, Torralba MG, Stenzel RD, Tovchigrechko A, Thovarai V, Harkins DM, Rajagopala SV, Osborne W, Cogen FR, Kaplowitz PB, Nelson KE, Madupu R, Pieper R
Theranostics 2017;7(10):2704-2717
Theranostics 2017;7(10):2704-2717
Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis.
Druhan LJ, Lance A, Li S, Price AE, Emerson JT, Baxter SA, Gerber JM, Avalos BR
PloS one 2017;12(1):e0170261
PloS one 2017;12(1):e0170261
Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms.
Satoh K, Maniwa T, Oda T, Matsumoto K
Proteome science 2013 Jun 27;11(1):27
Proteome science 2013 Jun 27;11(1):27
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.
Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, Stallings RL
Carcinogenesis 2012 May;33(5):976-85
Carcinogenesis 2012 May;33(5):976-85
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin.
Banfi C, Parolari A, Brioschi M, Barcella S, Loardi C, Centenaro C, Alamanni F, Mussoni L, Tremoli E
Journal of proteome research 2010 May 7;9(5):2347-57
Journal of proteome research 2010 May 7;9(5):2347-57
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- ELISA: LRG1 Antibody (2E3) [H00116844-M01] - Detection limit for recombinant GST tagged LRG1 is approximately 0.3ng/ml as a capture antibody.
